Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2002;33:2292-2296
doi: 10.1161/01.STR.0000027427.86177.D4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gunnett, C.A.
Right arrow Articles by Heistad, D.D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gunnett, C.A.
Right arrow Articles by Heistad, D.D.
Related Collections
Right arrow Acute Cerebral Hemorrhage
Right arrow Acute Cerebral Infarction
Right arrow Brain Circulation and Metabolism
Right arrow Vasculitis Brain Arteries
Right arrow Endothelium/vascular type/nitric oxide

(Stroke. 2002;33:2292.)
© 2002 American Heart Association, Inc.


Original Contributions

Gene Transfer of Inducible Nitric Oxide Synthase Impairs Relaxation in Human and Rabbit Cerebral Arteries

C.A. Gunnett, PhD; D.D. Lund, PhD; M.A. Howard, III, MD; Y. Chu, PhD; F.M. Faraci, PhD D.D. Heistad, MD

From the Departments of Medicine, Neurosurgery, and Pharmacology, University of Iowa College of Medicine and Veterans Affairs Medical Center, Iowa City, Iowa.

Correspondence to Carol A. Gunnett, PhD, Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, IA 52242-1081. E-mail Carol-Gunnett{at}uiowa.edu

Background and Purpose— These studies evaluated whether gene transfer of inducible nitric oxide synthase (iNOS) is a sufficient stimulus to produce vascular dysfunction in cerebral arteries.

Methods— Intracranial (pial) arteries were dissected from human brain tissue obtained during elective surgery. Isolated human arteries were incubated in vitro with adenovirus containing iNOS (AdiNOS) or a nonexpressive transgene (control, AdBglII) (500 µL, 3x109 plaque-forming units per milliliter), and vascular function was examined 24 hours later. In anesthetized rabbits, AdiNOS or AdBglII (300 µL 1x1010) was injected into the cisterna magna. Three days later, the basilar artery was removed, and reactivity was examined ex vivo.

Results— In submaximally precontracted vessels, we observed impairment of NO-dependent relaxation in human cerebral arteries after gene transfer of iNOS. Maximum relaxation to bradykinin (1 µmol/L, an endothelium-dependent agonist) was 77±11% (mean±SE) after AdBglII and 31±22% (P<0.05) after AdiNOS. After AdiNOS, responses to nitroprusside (an endothelium-independent NO donor) also were impaired. Responses to both nitroprusside and bradykinin were improved by aminoguanidine (300 µmol/L), an inhibitor of iNOS. AdiNOS produced no change in vasoconstrictor responses to U46619. In basilar arteries from rabbits examined in vitro after gene transfer in vivo, responses to histamine, serotonin, and nitroprusside all were similar after AdiNOS or AdBglII. In contrast, relaxation to acetylcholine was significantly depressed after AdiNOS. Maximum relaxation to acetylcholine (10 µmol/L) was 90±3% after AdBglII and 68±5% (P<0.05) after AdiNOS. Relaxation of arteries after AdiNOS was improved by aminoguanidine.

Conclusions— These studies suggest that expression of iNOS may impair NO-dependent relaxation in both human and rabbit cerebral arteries.


Key Words: acetylcholine • adenoviruses • bradykinin • nitric oxide • nitric oxide synthase • superoxides




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. V. R. Santhanam, L. A. Smith, K. A. Nath, and Z. S. Katusic
In vivo stimulatory effect of erythropoietin on endothelial nitric oxide synthase in cerebral arteries
Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H781 - H786.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. A. Gunnett, D. D. Lund, F. M. Faraci, and D. D. Heistad
Vascular interleukin-10 protects against LPS-induced vasomotor dysfunction
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H624 - H630.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
F. M. Faraci
Editorial Comment: eNOS: Can We Exploit the Good?
Stroke, January 1, 2005; 36(1): 160 - 161.
[Full Text] [PDF]


Home page
StrokeHome page
J. Sorenson, A. V. R. Santhanam, L. A. Smith, M. Akiyama, W. C. Sessa, and Z. S. Katusic
Expression and Function of Recombinant S1179D Endothelial NO Synthase in Human Pial Arteries
Stroke, January 1, 2005; 36(1): 158 - 160.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Hernanz, A. M. Briones, M. J. Alonso, E. Vila, and M. Salaices
Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteries
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H225 - H234.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. A. Gunnett, D. D. Heistad, and F. M. Faraci
Gene-Targeted Mice Reveal a Critical Role for Inducible Nitric Oxide Synthase in Vascular Dysfunction During Diabetes
Stroke, December 1, 2003; 34(12): 2970 - 2974.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. M. Faraci
Hyperhomocysteinemia: A Million Ways to Lose Control
Arterioscler Thromb Vasc Biol, March 1, 2003; 23(3): 371 - 373.
[Full Text] [PDF]


Home page
StrokeHome page
C. Iadecola and P. B. Gorelick
Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia
Stroke, February 1, 2003; 34(2): 335 - 337.
[Full Text] [PDF]